Takeda Pharmaceutical Company's total assets for Q4 2023 were ¥15.11T, an increase of 8.25% from the previous quarter. TAK total liabilities were ¥7.83T for the fiscal quarter, a -15.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.